C5 antibody
Quick Overview for C5 antibody (ABIN113312)
Target
See all C5 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Specificity
- Gives a single arc when tested by IEP against fresh Human plasma. Identity has been confirmed by Double Diffusion against fresh Human plasma and a known anti-Human C5.
-
Purification
- Ion Exchange Chromatography
-
Immunogen
- Human C5 purified from plasma
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Immunohistochemistry: 1/20-1/200 (as a guide). Immunodiffusion.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Glycine buffered saline, pH 7.4, containing 0.09 % Sodium Azide, 0.1 % EACA, 0.01 % Benzamidine and 1 mM EDTA
-
Preservative
- Sodium azide, Benzamidine, EACA
-
Precaution of Use
- This product contains Sodium azide, Benzamidine and EACA: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer. Avoid multiple freeze/thaw cycles.
-
-
- C5 (Complement Component 5 (C5))
-
Alternative Name
- Complement C5
-
Background
- C5 is synthesised in the liver as a single polypeptide chain. Before secretion the molecule is glycosylated and secreted into plasma as a 190 kDa glycoprotein consisting of a disulphide linked alpha-chain (111 kDa) and beta-chain (75 kDa). C5 precursor is first processed by the removal of 4 basic residues, forming two chains, beta and alpha, linked by a disulfide bond. C5 convertase activates C5 by cleaving the alpha chain, releasing C5a anaphylatoxin and generating C5b (beta chain + alpha' chain).Synonyms: C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4, CPAMD4, Complement component 5
-
Gene ID
- 727
-
NCBI Accession
- NP_001726
-
UniProt
- P01031
-
Pathways
- Complement System, Carbohydrate Homeostasis
Target
-